Bio-Rad Laboratories | BIO - Gross Profit On Sales



Bio-Rad Laboratories reported $355.9M in Gross Profit on Sales for its fiscal quarter ending in September of 2024.

Gross Profit On Sales Change Date
Abbott USD 5.94B 132M Sep/2024
Agilent USD 855M 0 Jul/2024
Becton, Dickinson and Co. USD 2.52B 208M Sep/2024
Bio Techne USD 183.2M 20.15M Sep/2024
Bio-Rad Laboratories USD 355.9M 183K Sep/2024
Bruker USD 418.8M 34.2M Sep/2024
Charles River Laboratories USD 367.77M 36K Sep/2024
Danaher USD 3.4B 27M Sep/2024
Exact Sciences USD 512.58M 3.16M Sep/2024
General Electric USD 2.93B 590M Sep/2024
Hologic USD 607.5M 10.5M Sep/2024
Illumina USD 745M 24M Sep/2024
IQVIA Holdings USD 915M 411M Sep/2024
Laboratory Of America USD 904.4M 22M Sep/2024
Merck USD 13.41B 975M Sep/2024
Mettler Toledo International USD 572.47M 6.8M Sep/2024
Myriad Genetics USD -22100000 169.2M Sep/2024
Quest Diagnostics USD 816M 12M Sep/2024
Repligen USD 77.49M 220K Sep/2024
Revvity USD 384.82M 690K Sep/2024
Roche Holding CHF 11.64B 9.41B Jun/2024
Siemens EUR 7.93B 178M Sep/2024
Standard Biotools USD 23.26M 8.35M Sep/2024
Thermo Fisher Scientific USD 4.42B 71M Sep/2024
Tosoh JPY 67.51B 8.78B Sep/2024
Waters USD 438.65M 18.37M Sep/2024